Allogeneic Stem Cell Transplant OK for Older AML Patients – MedPage Today
|
Allogeneic Stem Cell Transplant OK for Older AML Patients
MedPage Today A reduced-intensity conditioning regimen with hematopoietic stem–cell transplantation is fairly well tolerated and improves survival in older acute myelogenous leukemia (AML) patients in first clinical remission. In a group of patients ages 60 and … |
